Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Nu Skin
NUS
$233M
| $3.67M | ﹤0.01% |
56,720
+33,030
| +139% | +$1.86M |
|
2602
PUT
ProShares Short S&P500
SH
$824M
| $3.67M | ﹤0.01% |
24,125
-3,350
| -12% | -$514K |
|
2603
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
| $3.67M | ﹤0.01% |
69,372
+57,130
| +467% | +$3.02M |
|
2604
Dolby
DLB
$5.85B
| $3.67M | ﹤0.01% |
67,551
+26,572
| +65% | +$1.33M |
|
2605
National Healthcare
NHC
$3.48B
| $3.67M | ﹤0.01% |
55,549
+6,024
| +12% | +$391K |
|
|
CONE
2606
CALL
DELISTED
CyrusOne Inc Common Stock
CONE
| $3.66M | ﹤0.01% |
77,000
+55,700
| +262% | +$2.88M |
|
2607
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$826M
| $3.66M | ﹤0.01% |
235,370
+94,430
| +67% | +$1.48M |
|
2608
CALL
Meritage Homes
MTH
$4.6B
| $3.66M | ﹤0.01% |
211,000
+22,000
| +12% | +$400K |
|
2609
PUT
Waters Corp
WAT
$41.4B
| $3.66M | ﹤0.01% |
23,100
-30,300
| -57% | -$4.69M |
|
2610
PUT
Chemours
CC
$2.39B
| $3.66M | ﹤0.01% |
228,600
-106,300
| -32% | -$1.21M |
|
|
XIFR
2611
CALL
XPLR Infrastructure LP
XIFR
$1.11B
| $3.66M | ﹤0.01% |
130,700
+90,800
| +228% | +$2.74M |
|
|
ACIA
2612
DELISTED
Acacia Communications Inc
ACIA
| $3.65M | ﹤0.01% |
35,393
+8,427
| +31% | +$728K |
|
2613
PUT
Tower Semiconductor
TSEM
$24.8B
| $3.65M | ﹤0.01% |
240,200
+94,700
| +65% | +$1.37M |
|
2614
PUT
Allison Transmission
ALSN
$10.7B
| $3.64M | ﹤0.01% |
126,800
+7,300
| +6% | +$206K |
|
2615
PUT
OneMain Financial
OMF
$7.35B
| $3.64M | ﹤0.01% |
117,500
-51,700
| -31% | -$1.49M |
|
|
LN
2616
PUT
DELISTED
LINE Corporation
LN
| $3.63M | ﹤0.01% |
+75,100
| New | +$3.2M |
|
2617
CALL
Silicon Laboratories
SLAB
$7.31B
| $3.63M | ﹤0.01% |
61,800
+26,000
| +73% | +$1.4M |
|
2618
CALL
First Trust Natural Gas ETF
FCG
$673M
| $3.63M | ﹤0.01% |
137,300
+4,500
| +3% | +$113K |
|
|
FGP
2619
DELISTED
Ferrellgas Partners, L.P.
FGP
| $3.63M | ﹤0.01% |
+311,520
| New | +$5.83M |
|
|
SPLS
2620
DELISTED
Staples Inc
SPLS
| $3.62M | ﹤0.01% |
423,728
+115,588
| +38% | +$1.02M |
|
2621
CALL
New Oriental
EDU
$9.22B
| $3.62M | ﹤0.01% |
78,100
-29,100
| -27% | -$1.26M |
|
|
ARII
2622
PUT
DELISTED
American Railcar Industries, Inc.
ARII
| $3.62M | ﹤0.01% |
87,300
-93,400
| -52% | -$3.81M |
|
2623
Santander
BSBR
$42.9B
| $3.62M | ﹤0.01% |
563,945
| – | – |
|
2624
CALL
Nabors Industries
NBR
$1.36B
| $3.62M | ﹤0.01% |
5,946
+988
| +20% | +$487K |
|
2625
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.68B
| $3.61M | ﹤0.01% |
114,573
+50,804
| +80% | +$1.61M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.